Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Payables (2016 - 2025)

Palisade Bio has reported Payables over the past 16 years, most recently at $767000.0 for Q4 2025.

  • Quarterly Payables fell 30.59% to $767000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $767000.0 through Dec 2025, down 30.59% year-over-year, with the annual reading at $767000.0 for FY2025, 30.59% down from the prior year.
  • Payables was $767000.0 for Q4 2025 at Palisade Bio, down from $1.4 million in the prior quarter.
  • Over five years, Payables peaked at $1.8 million in Q4 2022 and troughed at $366000.0 in Q3 2024.
  • The 5-year median for Payables is $995500.0 (2022), against an average of $1.0 million.
  • Year-over-year, Payables crashed 61.47% in 2024 and then soared 289.62% in 2025.
  • A 5-year view of Payables shows it stood at $1.3 million in 2021, then surged by 32.96% to $1.8 million in 2022, then tumbled by 60.32% to $698000.0 in 2023, then soared by 58.31% to $1.1 million in 2024, then plummeted by 30.59% to $767000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Payables are $767000.0 (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025).